Alfred E. Tiefenbacher (GmbH & Co KG)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Alfred E. Tiefenbacher (GmbH & Co KG) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011865
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Alfred E. Tiefenbacher (GmbH & Co KG) (AET) is a healthcare products provider that develops active pharmaceuticals ingredients. The company’s products comprise cytotoxic drugs, hormones, OTC drugs, controlled drugs, herbal drugs, high potent drugs, new combination products, inhaler technologies, new delivery systems, modified release injection products and biosimilars. It offers products in the forms of tablets, capsules, solutions, patches, semisolids, injectables, ophthalmics, oral dissolving films, inhaled therapies and biologics. The company operates in India, Cyprus, Malta, China, Brazil and the US. AET is headquartered in Hamburg, Germany.

Alfred E. Tiefenbacher (GmbH & Co KG) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Alfred E. Tiefenbacher (GmbH & Co KG), Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Alfred E. Tiefenbacher (GmbH & Co KG), Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Alfred E. Tiefenbacher (GmbH & Co KG), Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Alfred E. Tiefenbacher (GmbH & Co KG), Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Alfred E. Tiefenbacher (GmbH & Co KG), Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Alfred E. Tiefenbacher (GmbH & Co KG), Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Alfred E. Tiefenbacher Receives Technology of Pramipexole from Hyundai Pharmaceutical 10
Alfred E. Tiefenbacher Forms Joint Venture with Combino Pharm 11
Licensing Agreements 12
Hyundai Pharm Enters Into Licensing Agreement With Alfred E. Tiefenbacher For Pramipexole SR 12
Alfred E. Tiefenbacher (GmbH & Co KG) – Key Competitors 13
Alfred E. Tiefenbacher (GmbH & Co KG) – Key Employees 14
Alfred E. Tiefenbacher (GmbH & Co KG) – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Joint Venture 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Alfred E. Tiefenbacher (GmbH & Co KG), Pharmaceuticals & Healthcare, Key Facts 2
Alfred E. Tiefenbacher (GmbH & Co KG), Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Alfred E. Tiefenbacher (GmbH & Co KG), Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Alfred E. Tiefenbacher (GmbH & Co KG), Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Alfred E. Tiefenbacher (GmbH & Co KG), Deals By Therapy Area, 2011 to YTD 2017 8
Alfred E. Tiefenbacher (GmbH & Co KG), Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Alfred E. Tiefenbacher Receives Technology of Pramipexole from Hyundai Pharmaceutical 10
Alfred E. Tiefenbacher Forms Joint Venture with Combino Pharm 11
Hyundai Pharm Enters Into Licensing Agreement With Alfred E. Tiefenbacher For Pramipexole SR 12
Alfred E. Tiefenbacher (GmbH & Co KG), Key Competitors 13
Alfred E. Tiefenbacher (GmbH & Co KG), Key Employees 14
Alfred E. Tiefenbacher (GmbH & Co KG), Subsidiaries 15
Alfred E. Tiefenbacher (GmbH & Co KG), Joint Venture 15

★海外企業調査レポート[Alfred E. Tiefenbacher (GmbH & Co KG)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Weifang Changan Steel Tower Stock Co Ltd:企業の戦略的SWOT分析
    Weifang Changan Steel Tower Stock Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Cosan S.A. Industria e Comercio (CSAN3):企業の財務・戦略的SWOT分析
    Cosan S.A. Industria e Comercio (CSAN3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • China General Technology (Group) Holding Ltd:企業の戦略・SWOT・財務情報
    China General Technology (Group) Holding Ltd - Strategy, SWOT and Corporate Finance Report Summary China General Technology (Group) Holding Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operati …
  • BlackRock Inc:企業の戦略・SWOT・財務情報
    BlackRock Inc - Strategy, SWOT and Corporate Finance Report Summary BlackRock Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Sucrerie Couplet SA:企業の戦略・SWOT・財務情報
    Sucrerie Couplet SA - Strategy, SWOT and Corporate Finance Report Summary Sucrerie Couplet SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Esco Technologies Inc (ESE):企業の財務・戦略的SWOT分析
    Esco Technologies Inc (ESE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Assembly Biosciences Inc (ASMB):製薬・医療:M&Aディール及び事業提携情報
    Summary Assembly Biosciences Inc (Assembly), formerly Ventrus Biosciences Inc is a biotechnology company that develops, discovers, and commercializes small molecule therapies. The company develops therapies for the treatment of infectious diseases such as microbiotic therapies for Clostridium diffic …
  • Vivendi S.A.:戦略・SWOT・企業財務分析
    Vivendi S.A. - Strategy, SWOT and Corporate Finance Report Summary Vivendi S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • CST Brands, Inc. (CST)-石油・ガス分野:企業M&A・提携分析
    Summary CST Brands, Inc. (CST) is a holding company,primarily involved in wholesaling and retailing motor fuels and convenience goods in North America. The company operates retail sites under Corner Store, Dépanneur du Coin banners, Flash Foods,Landmark, and Nice N Easy. Apart from motor fuel, these …
  • Alviva Holdings Ltd (AVV):企業の財務・戦略的SWOT分析
    Alviva Holdings Ltd (AVV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Bet Shemesh Engines Holdings (1997) Ltd:企業の戦略・SWOT・財務情報
    Bet Shemesh Engines Holdings (1997) Ltd - Strategy, SWOT and Corporate Finance Report Summary Bet Shemesh Engines Holdings (1997) Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Gulfport Energy Corp (GPOR):企業の財務・戦略的SWOT分析
    Gulfport Energy Corp (GPOR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Qc Holdings Inc
    Qc Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary Qc Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Genedata AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Genedata AG (Genedata) is a healthcare technology company that transforms data into software solutions. The company delivers enterprise solutions for data analytics that streamline research and development workflows and improve research productivity. Its products include genedata biologics, …
  • OGK-2 (OGKB):企業の財務・戦略的SWOT分析
    OGK-2 (OGKB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pote …
  • Charles River Laboratories International, Inc.:企業のM&A・事業提携・投資動向
    Charles River Laboratories International, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Charles River Laboratories International, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business descriptio …
  • NovoCure Ltd (NVCR):医療機器:M&Aディール及び事業提携情報
    Summary NovoCure Ltd (NovoCure) is an drug company that offers development and commercialization of novel therapies for tumor treating fields. The company’s pipeline products find application in cancer indications such as malignant melanoma, hepatocellular carcinoma, ovarian cancer, breast cancer an …
  • Tandem Diabetes Care Inc (TNDM):企業の財務・戦略的SWOT分析
    Summary Tandem Diabetes Care Inc (Tandem) is a medical device manufacturing company that designs and develops diabetic care products. The company's product portfolio includes t:slim X2 insulin pump, basal-IQ technology, software and applications, infusion sets and other pump accessories. It also pro …
  • MallInckrodt Plc (MNK):企業の財務・戦略的SWOT分析
    MallInckrodt Plc (MNK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Hualan Biological Engineering Inc (002007):企業の財務・戦略的SWOT分析
    Summary Hualan Biological Engineering Inc (Hualan Biological) is a biopharmaceutical company that develops vaccines. The company conducts research, develops and produces plasma, vaccines and gene products. Its plasma products include surgical lyophilized fibrin sealant, human coagulation factor VIII …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆